<?xml version="1.0" encoding="UTF-8"?>
<ref id="r93">
 <label>93</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Martens</surname>
   <given-names>CR</given-names>
  </string-name>, 
  <string-name>
   <surname>Denman</surname>
   <given-names>BA</given-names>
  </string-name>, 
  <string-name>
   <surname>Mazzo</surname>
   <given-names>MR</given-names>
  </string-name>, 
  <string-name>
   <surname>Armstrong</surname>
   <given-names>ML</given-names>
  </string-name>, 
  <string-name>
   <surname>Reisdorph</surname>
   <given-names>N</given-names>
  </string-name>, 
  <string-name>
   <surname>McQueen</surname>
   <given-names>MB</given-names>
  </string-name>, 
  <string-name>
   <surname>Chonchol</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Seals</surname>
   <given-names>DR</given-names>
  </string-name>. 
  <article-title>Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD
   <sup>+</sup> in healthy middle-aged and older adults.
  </article-title>
  <source>Nat Commun</source>. 
  <year>2018</year>; 
  <volume>9</volume>:
  <fpage>1286</fpage>â€“
  <lpage>11</lpage>. 
  <pub-id pub-id-type="doi">10.1038/s41467-018-03421-7</pub-id>
  <?supplied-pmid 29599478?>
  <pub-id pub-id-type="pmid">29599478</pub-id>
 </mixed-citation>
</ref>
